Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Non-Current Assets (2020 - 2025)

Celularity (CELU) has disclosed Non-Current Assets for 6 consecutive years, with $103.6 million as the latest value for Q3 2025.

  • On a quarterly basis, Non-Current Assets fell 9.35% to $103.6 million in Q3 2025 year-over-year; TTM through Sep 2025 was $425.6 million, a 10.81% decrease, with the full-year FY2024 number at $112.1 million, down 9.65% from a year prior.
  • Non-Current Assets was $103.6 million for Q3 2025 at Celularity, up from $103.0 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $374.0 million in Q3 2022 to a low of $103.0 million in Q2 2025.
  • A 5-year average of $220.8 million and a median of $140.7 million in 2023 define the central range for Non-Current Assets.
  • Peak YoY movement for Non-Current Assets: skyrocketed 175.7% in 2022, then plummeted 66.24% in 2023.
  • Celularity's Non-Current Assets stood at $355.0 million in 2021, then increased by 3.53% to $367.6 million in 2022, then crashed by 66.24% to $124.1 million in 2023, then fell by 9.65% to $112.1 million in 2024, then fell by 7.56% to $103.6 million in 2025.
  • Per Business Quant, the three most recent readings for CELU's Non-Current Assets are $103.6 million (Q3 2025), $103.0 million (Q2 2025), and $106.8 million (Q1 2025).